Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

E-Cadherin Expression in Relation to Clinicopathological Parameters and Survival of Patients with Epithelial Ovarian Cancer

19 Nov 2022

Abstract excerpt

It is generally accepted that loss/reduction of E-cadherin expression on tumor cells promotes their migration, invasiveness, and metastasis. It is also an indicator of cancer cells' aggressiveness. The aim of this study was to assess how the expression of E-cadherin varies in primary ovarian cancer tissue in regard to overall survival of patients; FIGO stage; grade; histopathological type of tumor; and potential...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Kruppel-like factors research
Share to Ovarian cancer diagnosis and treatment
Share to Wnt/β-catenin signaling in development and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36430858
DOI: 10.3390/ijms232214383

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

E-Cadherin Expression in Relation to Clinicopathological Parameters and Survival of Patients with Epithelial Ovarian CancerPMID 36430858Read ↗

E-cadherin: A determinant molecule associated with ovarian cancer progression, dissemination and aggressivenessSemantic proximity Read ↗

Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse OutcomesSemantic proximity Read ↗

Genome‑wide bioinformatics analysis reveals CTCFL is upregulated in high‑grade epithelial ovarian cancerSemantic proximity Read ↗

Integrin Subunit beta 8 (ITGB8) Upregulation Is an Independent Predictor of Unfavorable Survival of High-Grade Serous Ovarian Carcinoma PatientsSemantic proximity Read ↗

Machine learning and bioinformatics models to identify gene expression patterns of ovarian cancer associated with disease progression and mortalitySemantic proximity Read ↗

Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapySemantic proximity Read ↗

Pathologic chemotherapy response score in epithelial ovarian cancer: Surgical, genetic, and survival considerations.Semantic proximity Read ↗

The prognostic value of tumor-stroma ratio and a newly developed computer-aided quantitative analysis of routine H&E slides in high-grade serous ovarian cancerSemantic proximity Read ↗

Simultaneous E-cadherin and PLEKHA7 expression negatively affects E-cadherin/EGFR mediated ovarian cancer cell growthSemantic proximity Read ↗

The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patientsSemantic proximity Read ↗

19q12 amplified and non-amplified subsets of high grade serous ovarian cancer with overexpression of cyclin E1 differ in their molecular drivers and clinical outcomesSemantic proximity Read ↗

Low-grade epithelial ovarian cancer: a number of distinct clinical entities?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.